Friday, 4 February 2022

POST-BRIEFING LINKS

Information session on the mRNA vaccine technology transfer hub in South Africa

The audio file of today's information session on the objectives, functioning and progress of the mRNA vaccine technology transfer hub in South Africa is available here: https://who.canto.global/b/PFPPA

Speakers were:

• Dr Soumya Swaminathan, Chief Scientist, WHO
• Dr Martin Friede, Coordinator of the Initiative for Vaccine Research, WHO and the lead of the Long-Term Sustainable Manufacturing Workstream, COVAX Manufacturing Taskforce
• Charles Gore, Executive Director, Medicines Patent Pool

Additional information and resources:

• The mRNA vaccine technology transfer hub webpage
• FAQ on the mRNA vaccine technology hub

* * * * * * * * * *

What is the mRNA vaccine technology transfer hub?

The technology transfer hub, announced on 21 June 2021, aims to build capacity in low- and middle-income countries to produce mRNA vaccines through a centre of excellence and training (the mRNA vaccine technology hub).  The hub is located at Afrigen, Cape Town, South Africa and will work with a network of technology recipients (spokes) in low- and middle-income countries.

Media contacts:
mediainquiries@who.int

You are receiving this NO-REPLY email because you are included on a WHO mail list.
If you have been forwarded this update you can click here to subscribe.
Journalists may send feedback to WHO Media Team